(Q46462768)

22 December 2017

title

Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment (English)

1 reference

22 December 2017

0 references

0 references

D C Mohr

1

1 reference

22 December 2017

D E Goodkin

2

1 reference

22 December 2017

W Likosky

3

1 reference

22 December 2017

N Gatto

4

1 reference

22 December 2017

L K Neilley

5

1 reference

22 December 2017

C Griffin

6

1 reference

22 December 2017

B Stiebling

7

1 reference

22 December 2017

publication date

1 December 1996

1 reference

22 December 2017

Multiple Sclerosis Journal

published in

1 reference

22 December 2017

volume

2

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

222-226

1 reference

22 December 2017

https://api.crossref.org/works/10.1177%2F135245859600200502

1 reference

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600200502

Interferon beta treatment for multiple sclerosis: persisting questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600200502

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600200502

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600200502

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600200502

10.1177/135245859600200502

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017